TCL Archive FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment. March 31, 2000
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Panel Urges Research On DCIS To Identify Women At High Risk For Invasive Cancer September 25, 2009